Yuan Qing Qu

660 total citations
20 papers, 491 citations indexed

About

Yuan Qing Qu is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Yuan Qing Qu has authored 20 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yuan Qing Qu's work include Autophagy in Disease and Therapy (8 papers), Bioactive natural compounds (3 papers) and Ginseng Biological Effects and Applications (2 papers). Yuan Qing Qu is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Bioactive natural compounds (3 papers) and Ginseng Biological Effects and Applications (2 papers). Yuan Qing Qu collaborates with scholars based in Macao, China and United Kingdom. Yuan Qing Qu's co-authors include Vincent Kam Wai Wong, Betty Yuen Kwan Law, Yu Han, Simon Wing Fai Mok, Paolo Coghi, Liang Liu, Su Xu, Ni Zhang, Anguo Wu and Jianming Wu and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Yuan Qing Qu

20 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Qing Qu Macao 14 284 94 83 82 59 20 491
Amanda Garrido Spain 9 219 0.8× 77 0.8× 72 0.9× 99 1.2× 34 0.6× 11 524
Antonio Lupia Italy 14 279 1.0× 70 0.7× 87 1.0× 30 0.4× 49 0.8× 30 523
Kodihalli C. Ravindra United States 13 293 1.0× 82 0.9× 81 1.0× 30 0.4× 51 0.9× 22 699
Fanbo Jing China 13 274 1.0× 102 1.1× 59 0.7× 54 0.7× 62 1.1× 33 489
Anhui Gao China 14 390 1.4× 75 0.8× 125 1.5× 61 0.7× 57 1.0× 30 680
Gaurav Parashar India 14 379 1.3× 49 0.5× 55 0.7× 36 0.4× 72 1.2× 26 597
Leixiang Yang China 16 340 1.2× 124 1.3× 118 1.4× 55 0.7× 44 0.7× 31 621
Shengrong Li China 15 344 1.2× 72 0.8× 125 1.5× 30 0.4× 32 0.5× 58 597
Sonam Mittal India 14 406 1.4× 81 0.9× 53 0.6× 47 0.6× 111 1.9× 28 701
Souneek Chakraborty India 15 264 0.9× 107 1.1× 55 0.7× 37 0.5× 69 1.2× 21 433

Countries citing papers authored by Yuan Qing Qu

Since Specialization
Citations

This map shows the geographic impact of Yuan Qing Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Qing Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Qing Qu more than expected).

Fields of papers citing papers by Yuan Qing Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Qing Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Qing Qu. The network helps show where Yuan Qing Qu may publish in the future.

Co-authorship network of co-authors of Yuan Qing Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Qing Qu. A scholar is included among the top collaborators of Yuan Qing Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Qing Qu. Yuan Qing Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Linlin, Yong Tang, Yuan Qing Qu, et al.. (2025). Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma. Journal of Controlled Release. 381. 113605–113605. 10 indexed citations
2.
Qu, Yuan Qing, Jie Li, Shaomin Wang, et al.. (2025). Macrophage membrane-engineered biomimetic nanoplatform to potentiate STING pathway-mediated tumor immunotherapy. Chemical Engineering Journal. 517. 164323–164323. 1 indexed citations
4.
Qu, Yuan Qing, Linlin Song, Su Xu, et al.. (2023). Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo. Pharmacological Research. 191. 106769–106769. 15 indexed citations
5.
Wang, Lu, et al.. (2023). Case report: A case of pulmonary mucormycosis caused by Rhizopus azygosporus infection complicated by type 2 diabetes mellitus. Frontiers in Medicine. 10. 1240436–1240436. 1 indexed citations
6.
Ng, Jerome P. L., Yuan Qing Qu, Betty Yuen Kwan Law, et al.. (2022). Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes. Pharmaceuticals. 15(3). 360–360. 10 indexed citations
7.
Cheng, Shasha, Yuan Qing Qu, Jia Wu, et al.. (2021). Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer. Acta Pharmaceutica Sinica B. 12(3). 1390–1405. 49 indexed citations
8.
Hamdoun, Sami, Ruihong Chen, Yuan Qing Qu, et al.. (2021). Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacological Research. 172. 105820–105820. 69 indexed citations
9.
Qu, Yuan Qing, Betty Yuen Kwan Law, Yu Han, et al.. (2021). AGEs-Induced Calcification and Apoptosis in Human Vascular Smooth Muscle Cells Is Reversed by Inhibition of Autophagy. Frontiers in Pharmacology. 12. 692431–692431. 12 indexed citations
10.
Huang, Qi, Li Bai, Betty Yuen Kwan Law, et al.. (2020). Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism. Cell Death and Disease. 11(8). 621–621. 16 indexed citations
11.
Yaremenko, Ivan A., Paolo Coghi, Parichat Prommana, et al.. (2020). Synthetic Peroxides Promote Apoptosis of Cancer Cells by Inhibiting P‐Glycoprotein ABCB5. ChemMedChem. 15(13). 1118–1127. 36 indexed citations
13.
Ribaudo, Giovanni, Paolo Coghi, Betty Yuen Kwan Law, et al.. (2019). Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer’s disease. Bioorganic Chemistry. 87. 474–483. 30 indexed citations
14.
Law, Betty Yuen Kwan, Francesco Michelangeli, Yuan Qing Qu, et al.. (2019). Neferine induces autophagy-dependent cell death in apoptosis-resistant cancers via ryanodine receptor and Ca2+-dependent mechanism. Scientific Reports. 9(1). 20034–20034. 44 indexed citations
15.
Leung, Elaine Lai Han, Zhong Qiu Liu, Vincent Kam Wai Wong, et al.. (2018). Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity. Cell Death and Disease. 9(2). 216–216. 42 indexed citations
16.
Zhou, Xiaobo, Yuan Qing Qu, Zhiyuan Zheng, et al.. (2018). Novel dauricine derivatives suppress cancer via autophagy-dependent cell death. Bioorganic Chemistry. 83. 450–460. 17 indexed citations
17.
Qu, Yuan Qing, Betty Yuen Kwan Law, Yu Han, et al.. (2018). 2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy. Cell Death and Disease. 9(3). 361–361. 16 indexed citations
18.
Law, Betty Yuen Kwan, Simon Wing Fai Mok, Juan Chen, et al.. (2017). N-Desmethyldauricine Induces Autophagic Cell Death in Apoptosis-Defective Cells via Ca2+ Mobilization. Frontiers in Pharmacology. 8. 388–388. 23 indexed citations
19.
Law, Betty Yuen Kwan, Yuan Qing Qu, Simon Wing Fai Mok, et al.. (2017). New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers. Oncotarget. 8(33). 55003–55021. 33 indexed citations
20.
Law, Betty Yuen Kwan, Yuan Qing Qu, Ni Zhang, et al.. (2017). Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. Oncotarget. 8(18). 30077–30091. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026